Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2015/03/005613
CTRI/2015/03/005613
Active, Not Recruiting
Phase 4

An evaluation of use of botulinum toxin type A in the management of dynamic forehead wrinkles- A clinical study

Dr L Krishna Prasad Head of department Department of oral and maxillofacial surgery0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr L Krishna Prasad Head of department Department of oral and maxillofacial surgery
Status
Active, Not Recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Dr L Krishna Prasad Head of department Department of oral and maxillofacial surgery

Eligibility Criteria

Inclusion Criteria

  • •Willing for participation in the study protocol
  • •aesthetic facial corrections of forehead wrinkles

Exclusion Criteria

  • •Pregnant patients
  • •allergic to botulinum toxin
  • •Not willing to include in study protocol
  • •underlying pathology of skin
  • •medically compromised patients

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
N/A
comparison of the effect of botulinium toxin A injection with placebo in reducing the pain of patients with myofacial paitemporomandibular disorder.Temporomandibular joint disorders
IRCT2016051527894N2Vice chancellor for research of Ahvaz Jundishapur University of Medical Sciences34
Completed
Phase 2
Assessment of the botulinum toxin type A effect on Intensified Raynauds Phenomenon in Sclerodermic patientsSystemic sclerosis [scleroderma].Systemic sclerosis [scleroderma]
IRCT20200106046023N1Oroumia University of Medical Sciences11
Active, Not Recruiting
Phase 1
botulinum toxin for the treatment of chronic anal fissureChronic anal fissureTherapeutic area: Not possible to specify
EUCTR2017-001216-11-ESDra. A. Teresa Calderón Duque
Recruiting
Phase 3
Evaluation the effect of Botulinium toxin injection on improving symptoms in patients with diabetic neuropathy
IRCT20240116060710N1Shahid Beheshti University of Medical Sciences30
Not Yet Recruiting
N/A
Assessment of Botulinum Toxin Type A in the Treatment of Hand Eczema
PACTR201704002194318Dermatology Department, Faculty of Medicine, University of Alexandria60